CCL Industries (CCL-B) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
11 Nov, 2026Executive summary
Q3 sales were $2,219.9 million, up 12.9% reported, 11% excluding FX and 6.9% organically; operating income rose 10.7% reported and 8% excluding FX to $356.3 million.
Q3 net earnings were $223.6 million versus $210.8 million; adjusted basic EPS was $1.36, up 12.4%.
Nine-month sales were $6,269.1 million, up 8.3% reported and 7% excluding FX; operating income rose 6.6% reported and 5% excluding FX to $1,024.4 million.
Nine-month net earnings increased 3.3% to $652.3 million; adjusted basic EPS was $3.91, up 8.3%.
Financial highlights
Q3 EBITDA was $461.7 million, up 8%; nine-month EBITDA was $1,326.7 million, up 5%.
Q3 gross profit increased to $648.3 million from $595.0 million; restructuring and other items were $5.2 million versus $1.6 million.
Q3 free cash flow from operations was $236.5 million versus $333.4 million; nine-month free cash flow was $463.0 million and operating cash flow was $765.0 million.
Q3 effective tax rate was 27.7% versus 25.5%, reflecting higher income in higher-tax jurisdictions and higher withholding taxes.
Segment performance
CCL segment Q3 sales were $1,446.7 million, up 14.8% reported and 12% excluding FX; operating income was $228.9 million, up 5.8% reported and 3% excluding FX, with a 15.8% margin.
Avery sales were $299.7 million, up 7.3% reported and 5% excluding FX; operating income rose 14.7% to $60.9 million, with margin expanding 130 bps to 20.3%.
Checkpoint sales were $260.0 million, up 1.8% reported and 1% excluding FX; operating income rose 2.1% to $39.6 million, with margin unchanged at 15.2%.
Innovia sales were $213.5 million, up 25.1% reported and 24% excluding FX; operating income rose 97.8% to $26.9 million, with margin expanding 460 bps to 12.6%.
CCL gained in Healthcare, Food & Beverage and HPC labels; Avery benefited from direct-to-consumer growth, Checkpoint from RFID, and Innovia from EcoFloat, Americas gains and productivity; memory-chip constraints weighed on design demand.
Latest events from CCL Industries
- FY adjusted EPS reached $3.76 as Q4 results and early-2024 orders improved.CCL-B
Q4 2023 - Q2 2026 saw record sales, EPS growth, and strong cash flow, led by CCL and Innovia.CCL-B
Q2 2026 - Sales up 2.8%, adjusted EPS rose, and cash flow strong despite inflationary headwinds.CCL-B
Q1 2026 - Record sales, earnings, and free cash flow in 2025, with increased shareholder returns.CCL-B
Q4 2025 - Q3 sales and EPS rose, cash flow was strong, and $467.9M was returned to shareholders.CCL-B
Q3 2025 - Q3 2024 delivered strong sales and earnings growth, led by RFID and robust liquidity.CCL-B
Q3 2024 - Q2 2024 saw double-digit sales and profit growth, led by RFID and a major acquisition gain.CCL-B
Q2 2024 - Q1 2025 saw record sales, earnings, and cash flow, with robust shareholder returns.CCL-B
Q1 2025 - Record 2024 sales and earnings, strong cash flow, and positive but cautious 2025 outlook.CCL-B
Q4 2024